FRIBERG GREGORY R (EVP, Chief R&D Officer) received a stock award from BIOMARIN PHARMACEUTICAL INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2026ACC: 0001628280-26-019266
Officer· EVP, Chief R&D Officer
Since Feb 2026
+63.12K
Net shares
Net buyer
$91.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
64.75K acquired · 1.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+19.15K
Price / share
—
Trade value
—
% of position
51.0%
3/16/2026
37.58K→56.73K
Common Stock
Direct
Shares
−1.63K
Price / share
$56.05
Trade value
$91.31K
% of position
2.9%
3/17/2026
56.73K→55.10K
Total
Net shares
+17.52K
Net value
-$91.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | A · Award | +19.15K | — | — | 51.0% | 37.58K | 56.73K |
| Common Stock Direct | 3/17/2026 | F · Tax Withholding | −1.63K | $56.05 | $91.31K | 2.9% | 56.73K | 55.10K |
| Total | +17.52K | -$91.31K | ||||||
Derivative Transactions1
Stock Option (Right to Buy Common Stock)
Direct
Converts to
Common Stock
45.60K shares
Shares
+45.60K
Strike price
57.43
Held after
45.60K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock) Direct | Common Stock45.60K shares | 3/16/2026 | A · Award | +45.60K | 57.43 | — | 45.60K |